acromegaly
ACROMEGALY
Acromegaly is a chronic, slowly developing disease with progressive disfigurement and disability. An early diagnosis is difficult as most signs and symptoms are due to long-standing overproduction of growth hormone &/or insulin-like growth factor (IGF-I) causing metabolic, endocrine and morphological changes.
Surgical intervention is the first-line of treatment for almost all patients with acromegaly unless there are contraindications or the patient refuses to undergo the procedure.

Definition

  • A chronic, slowly developing disease with progressive disfigurement and disability
  • An early diagnosis is difficult as most signs and symptoms are due to long-standing overproduction of growth hormone (GH) and/or insulin-like growth factor (IGF-I) causing metabolic, endocrine and morphological changes

Epidemiology

  • Uncommon disorder and in Europe, it has a prevalence of 30-70 individuals per million
  • Mean age of diagnosis is in the early to mid-40s in both males and females
  • Due to its insidious onset diagnosis is often delayed

Signs and Symptoms

Symptoms due to excess growth hormone (GH) and/or insulin-like growth factor (IGF-I):

  • Soft tissue swelling and extremities enlargement
  • Hyperhidrosis (excessive sweating)
  • Hypogonadism symptoms
  • Coarsening of facial features
  • Prognathism
  • Macroglossia
  • Arthritis
  • Gigantism
  • Increased incidence of obstructive sleep apnea
  • Increased incidence of diabetes mellitus (glucose intolerance)
  • Increased incidence of cardiovascular diseases [hypertension, coronary heart disease (CHD)]
  • Metabolic effects: Hyperphosphatemia, hypercalciuria, hypertriglyceridemia and low high-density lipoprotein-C (HDL-C)
  • Increased incidence of colonic polyps and adenocarcinoma of colon

Symptoms due to pressure caused by suprasellar extension of pituitary adenoma:

  • Visual field defects
  • Diplopia (secondary to cranial nerve palsy)
  • Headache
  • Loss of pituitary function resulting in lethargy, menstrual dysfunction, erectile dysfunction, infertility and loss of libido

Pathophysiology

  • More than 95% of patients with acromegaly has hypersecretion of growth hormone and insulin-like growth factor-1 secondary to growth hormone-secreting pituitary adenoma that arise from somatotroph cells
    • In response to inducing signals including hypothalamic growth hormone-releasing hormone, growth hormone is synthesized and stored in the somatotroph cells (GHRH)
    • Production of growth hormone is suppressed by somatostatin signaling primarily through the somatostatin receptor subtype 2
    • Peripheral signals (eg insulin growth factor, steroid and paracrine growth factors) also regulates production of growth hormone
  • While <5% of patients with acromegaly have excess growth hormone secretion from a hypothalamic tumor or a neuroendocrine tumor that leads to somatotroph hyperplasia and acromegaly

Etiology

 Other Possible Causes of Acromegaly

  • Rarely, from ectopic pituitary tumor or ectopic production of growth hormone by other tumors like cancers of pancreas or lung
  • May also be caused by ectopic production of growth hormone releasing hormone (GHRH) by a tumor in the hypothalamus or tumors of the pancreas, kidney and lungs
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 14 Nov 2019

Patients with type 2 diabetes (T2D) and severe obesity may have a greater chance of complete T2D remission 1 year after gastric bypass rather than sleeve gastrectomy, according to results of the Oseberg* trial.

02 May 2019
At a recent Abbott lunch symposium held in conjunction with the joint 12th International Diabetes FederationWestern Pacific Region Congress & 10th Asian Association for the Study of Diabetes Scientific Meeting in KualaLumpur, Professor Shashank R. Joshi extensively discussed the issue of diabetes in obesity and the role of nutritionalintervention in addressing this growing problem.
Dr Joslyn Ngu, 19 Jun 2018

The transcultural Diabetes Nutrition Algorithm (tDNA) which involves a structured low-calorie meal plan, diabetes-specific meal replacements and enhanced physical activity, is effective for weight loss in patients with type 2 diabetes, a local study shows. [BMJ Open Diabetes Res Care 2017;5(1):e000384. Doi:10.1136/bmjdrc-2016-000384th]